Literature DB >> 26989794

Do psychotherapies produce neurobiological effects?

Veena Kumari1.   

Abstract

BACKGROUND: An area of recent interest in psychiatric research is the application of neuroimaging techniques to investigate neural events associated with the development and the treatment of symptoms in a number of psychiatric disorders.
OBJECTIVE: To examine whether psychological therapies modulate brain activity and, if so, to examine whether these changes similar to those found with relevant pharmacotherapy in various mental disorders.
METHODS: Relevant data were identified from Pubmed and PsycInfo searches up to July 2005 using combinations of keywords including 'psychological therapy', 'behaviour therapy', 'depression', 'panic disorder', 'phobia', 'obsessive compulsive disorder', 'schizophrenia', 'psychosis', 'brain activity', 'brain metabolism', 'PET', 'SPECT' and 'fMRI'.
RESULTS: There was ample evidence to demonstrate that psychological therapies produce changes at the neural level. The data, for example in depression, panic disorder, phobia and obsessive compulsive disorder (OCD), clearly suggested that a change in patients' symptoms and maladaptive behaviour at the mind level with psychological techniques is accompanied with functional brain changes in relevant brain circuits. In many studies, cognitive therapies and drug therapies achieved therapeutic gains through the same neural pathways although the two forms of treatment may still have different mechanisms of action.
CONCLUSIONS: Empirical research indicates a close association between the 'mind' and the 'brain' in showing that changes made at the mind level in a psychotherapeutic context produce changes at the brain level. The investigation of changes in neural activity with psychological therapies is a novel area which is likely to enhance our understanding of the mechanisms for therapeutic changes across a range of disorders.

Entities:  

Year:  2006        PMID: 26989794     DOI: 10.1111/j.1601-5215.2006.00127.x

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  7 in total

1.  Neuroplasticity, psychosocial genomics, and the biopsychosocial paradigm in the 21st century.

Authors:  Eric L Garland; Matthew Owen Howard
Journal:  Health Soc Work       Date:  2009-08

2.  Individualized and clinically derived stimuli activate limbic structures in depression: an fMRI study.

Authors:  Henrik Kessler; Svenja Taubner; Anna Buchheim; Thomas F Münte; Michael Stasch; Horst Kächele; Gerhard Roth; Armin Heinecke; Peter Erhard; Manfred Cierpka; Daniel Wiswede
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

3.  Altered resting-state functional connectivity of the default mode and central executive networks following cognitive processing therapy for PTSD.

Authors:  Tessa C Vuper; Carissa L Philippi; Steven E Bruce
Journal:  Behav Brain Res       Date:  2021-04-22       Impact factor: 3.352

4.  Tracking functional brain changes in patients with depression under psychodynamic psychotherapy using individualized stimuli.

Authors:  Daniel Wiswede; Svenja Taubner; Anna Buchheim; Thomas F Münte; Michael Stasch; Manfred Cierpka; Horst Kächele; Gerhard Roth; Peter Erhard; Henrik Kessler
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 5.  Disentangling the Neural Basis of Cognitive Behavioral Therapy in Psychiatric Disorders: A Focus on Depression.

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Brain Sci       Date:  2018-08-09

6.  Structural magnetic resonance imaging predictors of responsiveness to cognitive behaviour therapy in psychosis.

Authors:  Preethi Premkumar; Dominic Fannon; Elizabeth Kuipers; Emmanuelle R Peters; Ananatha P P Anilkumar; Andrew Simmons; Veena Kumari
Journal:  Schizophr Res       Date:  2009-09-05       Impact factor: 4.939

7.  Cognitive Behavioral Therapy Normalizes Functional Connectivity for Social Threat in Psychosis.

Authors:  Liam Mason; Emmanuelle R Peters; Danai Dima; Steven C Williams; Veena Kumari
Journal:  Schizophr Bull       Date:  2015-10-27       Impact factor: 9.306

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.